0001827635
Company

Veradermics, Inc

Pharmaceutical Preparations · MANE

ipo trading priced NYSE 424B4

Filing Timeline

SEC EDGAR
CERT inactive
CERT
Pre-IPO filing captured from the SEC submission timeline.
Follows FWP in the pre-IPO sequence.
2026-02-04 · 0000876661-26-000084
424B4 priced
Final prospectus
Final prospectus filed after pricing with final deal terms.
Follows CERT and confirms the priced prospectus.
2026-02-04 · 0001628280-26-005505
8-A12B effective
Exchange Act registration
Registration filed to list the securities under the Exchange Act ahead of trading.
Follows EFFECT and registers the class of securities for exchange listing.
2026-02-03 · 0001628280-26-005106
FWP supplemental
Free writing prospectus
Prospectus supplement or marketing filing that often updates active offering terms.
Follows 8-A12B and supplements the active offering with updated prospectus details.
2026-02-03 · 0001827635-26-000005
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows S-1/A and marks the registration effective.
2026-01-30 · 9999999995-26-000407
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1 filing.
2026-01-28 · 0001628280-26-003764
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows DRS in the pre-IPO sequence.
2026-01-09 · 0001628280-26-001651
DRS filed
Draft registration statement
Draft registration filed confidentially before the public launch.
First tracked pre-IPO filing for this issuer.
2025-10-27 · 0001628279-25-000707

Recent News

No recent news stored for this issuer.